drugset / Trial / NCT00813904
Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the immunogenicity and safety of recombinant Thrombin (rThrombin) in patients with prior rThrombin exposure.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rThrombin | Protein / enzyme biologic | 1000 iu | Topical |
Indications
No indication recorded.